Concepedia

Publication | Closed Access

Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab

DOI

135

Citations

28

References

2019

Year

Anthony Dohan, B. Gallix, Boris Guiu, Karine Le Malicot, Caroline Reinhold, Philippe Soyer, Jaafar Bennouna, François Ghiringhelli, Emilie Barbier, Valérie Boige,
Gut

Abstract

Clinicaltrial.gov identifier of the PRODIGE 9 study: NCT00952029.Clinicaltrial.gov identifier of the PRODIGE 20 study: NCT01900717.

References

YearCitations

Page 1